Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
about
Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis: Efficacy of 7 targeted therapies for AHCC.Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany - are additional data requirements by the Federal Joint Committee justified?First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany.
P2860
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Relevance of indirect comparis ...... n England, France and Scotland
@ast
Relevance of indirect comparis ...... n England, France and Scotland
@en
type
label
Relevance of indirect comparis ...... n England, France and Scotland
@ast
Relevance of indirect comparis ...... n England, France and Scotland
@en
prefLabel
Relevance of indirect comparis ...... n England, France and Scotland
@ast
Relevance of indirect comparis ...... n England, France and Scotland
@en
P2093
P2860
P1476
Relevance of indirect comparis ...... n England, France and Scotland
@en
P2093
Andrea Lebioda
David Gasche
Franz-Werner Dippel
Karlheinz Theobald
Stefan Plantör
P2860
P2888
P356
10.1186/S13561-014-0031-5
P577
2014-11-30T00:00:00Z
P5875
P6179
1019289712